Di Munno O - Search Results

1

Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus.

Carli L, Tani C, Spera V, Vagelli R, Vagnani S, Mazzantini M, Di Munno O, Mosca M. Carli L, et al. Among authors: di munno o. Lupus Sci Med. 2016 Jan 19;3(1):e000098. doi: 10.1136/lupus-2015-000098. eCollection 2016. Lupus Sci Med. 2016. PMID: 26848397 Free PMC article.

2

Risk factors for osteoporosis in female patients with systemic lupus erythematosus.

Di Munno O, Mazzantini M, Delle Sedie A, Mosca M, Bombardieri S. Di Munno O, et al. Lupus. 2004;13(9):724-30. doi: 10.1191/0961203303lu1097oa. Lupus. 2004. PMID: 15485112 Review.

3

Long-term prospective study of osteoporotic patients treated with percutaneous vertebroplasty after fragility fractures.

Mazzantini M, Carpeggiani P, d'Ascanio A, Bombardieri S, Di Munno O. Mazzantini M, et al. Among authors: di munno o. Osteoporos Int. 2011 May;22(5):1599-607. doi: 10.1007/s00198-010-1341-z. Epub 2010 Jul 27. Osteoporos Int. 2011. PMID: 20661546

4

Glucocorticoid-induced osteoporosis: 2013 update.

Mazzantini M, Di Munno O. Mazzantini M, et al. Among authors: di munno o. Reumatismo. 2014 Jul 28;66(2):144-52. doi: 10.4081/reumatismo.2014.787. Reumatismo. 2014. PMID: 25069496 Free article. Review.

5

High rate of vertebral refracture after vertebroplasty in patients taking glucocorticoids: a prospective two-year study.

Mazzantini M, Figliomeni A, Bottai V, Manca ML, Puglioli M, Di Munno O, Mosca M. Mazzantini M, et al. Among authors: di munno o. Clin Exp Rheumatol. 2020 Jul-Aug;38(4):649-653. Epub 2019 Nov 20. Clin Exp Rheumatol. 2020. PMID: 31820731 Free article.

6

Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis.

Di Munno O, Mazzantini M, Massei P, Ferdeghini M, Pitaro N, Latorraca A, Ferri C. Di Munno O, et al. Clin Rheumatol. 1995 Jul;14(4):407-12. doi: 10.1007/BF02207673. Clin Rheumatol. 1995. PMID: 7586976

7

Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate.

Mazzantini M, Di Munno O, Incerti-Vecchi L, Pasero G. Mazzantini M, et al. Among authors: di munno o. Clin Exp Rheumatol. 2000 May-Jun;18(3):327-31. Clin Exp Rheumatol. 2000. PMID: 10895369 Clinical Trial.

8

Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study.

Mazzantini M, Di Munno O, Sinigaglia L, Bianchi G, Rossini M, Mela Q, Del Puente A, Frediani B, Cantatore F, Adami S. Mazzantini M, et al. Among authors: di munno o. Clin Exp Rheumatol. 2007 Sep-Oct;25(5):709-15. Clin Exp Rheumatol. 2007. PMID: 18078618 Clinical Trial.

9

Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study.

Mazzantini M, Torre C, Miccoli M, Baggiani A, Talarico R, Bombardieri S, Di Munno O. Mazzantini M, et al. Among authors: di munno o. J Rheumatol. 2012 Mar;39(3):552-7. doi: 10.3899/jrheum.110851. Epub 2012 Jan 15. J Rheumatol. 2012. PMID: 22247343

10

Deflazacort versus methylprednisolone in polymyalgia rheumatica: clinical equivalence and relative antiinflammatory potency of different treatment regimens.

Di Munno O, Imbimbo B, Mazzantini M, Milani S, Occhipinti G, Pasero G. Di Munno O, et al. J Rheumatol. 1995 Aug;22(8):1492-8. J Rheumatol. 1995. PMID: 7473472 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters